Kendra S. Carmon

University Of Texas Hlth Sci Ctr Houston

$3,557,490

Attributed

$3,557,490

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.2M · FY2018–25

$2M$1.5M$1M$500K$0

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$3,557,490 · 6

By mechanism

R01$2,157,417 · 2

R21$1,400,073 · 4

Top collaborators

No co-investigators on record.

Most similar at University Of Texas Hlth Sci Ctr Houston

Same institution · by research overlap

Qingyun Liu$2,770,299
Kyoji Tsuchikama$3,574,789

Others in their field

Other Emerging Leaders on “Neoplasm Metastasis”

Rachana Agarwal · Leidos Biomedical Research, Inc.$15,241,462
Mark Raymond Nelson · Hennepin Healthcare Research Institute$6,702,147
Samuel F Bakhoum · Weill Medical Coll Of Cornell Univ$6,006,178
Vesteinn Thorsson · Institute For Systems Biology$5,781,130
Andrew Josef Ewald · Johns Hopkins University$5,735,880
Kevin L. Gardner · Columbia University Health Sciences$5,645,546

Research focus

Neoplasm MetastasisAntibody-Drug ConjugatesResistanceRelapseTumorColon Cancer Cell LineKnock-DownTargeted TreatmentCancer Stem CellAffinityG-Protein-Coupled ReceptorsOrganoidsCellsSelf-RenewalCancer CellLeucine-Rich RepeatTumor GrowthGrowthPathway InteractionsEffective TherapyGeneticAblationLgr5 GeneChemotherapy